Showing results (391-400 of 2,196) with videos related to
Sort By:
Pageof 220
Health Economics|August 19, 2009
Improving costing methods in multicentre economic evaluation: the use of multiple imputation for unit costsRichard Grieve, John Cairns, Simon G ThompsonCancer|December 18, 2001
A Phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar)S Bates, M Kang, B Meadows, et al.Clinical Pharmacology and Therapeutics|April 1, 2011
Effect of ABCC2 (MRP2) transport function on erythromycin metabolismR M Franke, C S Lancaster, C J Peer, et al.Biopharmaceutics & Drug Disposition|May 1, 1997
Pharmacokinetics of elemental platinum (ultrafiltrate and total) after a thirty minute intravenous infusion of ormaplatinW D Figg, M C Christian, R Lush, et al.Microvascular Research|June 30, 2000
Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesisA C Berger, H R Alexander, G Tang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancerA Thibault, D Samid, A C Tompkins, et al.Statistics in Medicine|September 28, 2011
Allowing for missing outcome data and incomplete uptake of randomised interventions, with application to an Internet-based alcohol trialIan R White, Eleftheria Kalaitzaki, Simon G ThompsonStatistics in Medicine|May 2, 2009
Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analysesDan Jackson, Ian R White, Simon G ThompsonCurrent Biology : CB|September 21, 2000
The dynamics of velocity adaptation in human visionS T Hammett, P G Thompson, S BedinghamBritish Medical Journal|May 10, 1980
Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparationsT W Meade, G Greenberg, S G ThompsonPageof 220